Skip to product information
1 of 11

OGDH Mouse mAb

OGDH Mouse mAb

Catalog Number: S0B60188 Application: WB, IHC-P, ICC Reactivity: Hu, Ms, Rt Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen OGDH
Synonyms 2-oxoglutarate dehydrogenase complex component E1; E1o; HsOGDH; OGDC-E1; OGDH-E1; 2-oxoglutarate dehydrogenase; mitochondrial; Alpha-ketoglutarate dehydrogenase (Alpha-KGDH-E1); Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase
Location Nucleus, Mitochondrion
Accession Q02218
Antibody Type Mouse mAb
Isotype IgG2b
Application WB, IHC-P, ICC
Reactivity Hu, Ms, Rt
Positive Sample mouse heart, rat heart
Purification Protein A
Concentration 1.3 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000-1:5000 Hu, Ms, Rt
IHC-P 1:100-1:500 Hu, Ms, Rt
ICC 1:200-1:500 Hu, Ms, Rt

Background

OGDH is the core subunit of the α-ketoglutarate dehydrogenase complex (OGDC) in the mitochondrial matrix. As one of the key rate-limiting enzymes of the tricarboxylic acid (TCA) cycle, it catalyzes the oxidative decarboxylation of α-ketoglutarate to succinyl-CoA and NADH, connecting two important metabolic nodes in the cycle and playing a critical role in cellular energy metabolism and redox balance. This enzyme is encoded by the OGDH gene, which is located on human chromosome 7 and encodes a precursor protein with an N-terminal mitochondrial targeting sequence that is processed to form the functional mature enzyme. Structurally, the OGDH protein consists of three domains: the N-terminal domain is responsible for binding the coenzyme thiamine pyrophosphate (TPP) to support substrate decarboxylation, the central region mediates homodimer formation, and the C-terminus contains the interaction interface for binding to dihydrolipoamide dehydrogenase (E3). Due to its central role in metabolism, OGDH activity is regulated by multiple mechanisms, including substrate availability, product inhibition, and phosphorylation modification. At the pathological level, OGDH dysfunction is closely associated with various neurological disorders; studies have found that its activity is significantly reduced in brain tissues of patients with Alzheimer's disease and Parkinson's disease, representing an important mechanism by which impaired energy metabolism contributes to neurodegeneration. In addition, OGDH gene mutations have also been linked to neurodevelopmental disorders such as early-onset dystonia and Leigh syndrome. In recent years, OGDH has also been recognized as a metabolic vulnerability in multiple tumors, and its inhibition represents a therapeutic strategy for targeting tumor metabolism.

Picture

Western Blot

WB result of OGDH Mouse mAb
Primary antibody: OGDH Mouse mAb at 1/2500 dilution
Lane 1: mouse heart lysate 20 µg
Secondary antibody: Goat Anti- mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 116 kDa
Observed MW: 116 kDa

WB result of OGDH Mouse mAb
Primary antibody: OGDH Mouse mAb at 1/2500 dilution
Lane 1: rat heart lysate 20 µg
Secondary antibody: Goat Anti- mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 116 kDa
Observed MW: 116 kDa

Immunohistochemistry

IHC shows positive staining in paraffin-embedded human cardiac muscle. Anti-OGDH antibody was used at 1/200 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human kidney. Anti-OGDH antibody was used at 1/200 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human lung cancer. Anti-OGDH antibody was used at 1/200 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded mouse kidney. Anti-OGDH antibody was used at 1/200 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded rat kidney. Anti-OGDH antibody was used at 1/200 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Immunocytochemistry

ICC shows positive staining in HepG2 cells. Anti-OGDH antibody was used at 1/400 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Mouse IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).